Thrombocytosis Associated with Enzyme Replacement Therapy in Gaucher Disease

Publisher： Karger

E-ISSN： 1421-9662|108|2|94-96

ISSN： 0001-5792

Source： Acta Haematologica, Vol.108, Iss.2, 2002-08, pp. : 94-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ATTEMPT AT ENZYME REPLACEMENT IN GAUCHER DISEASE BY RENAL TRANSPLANTATION

By  

ACTA PAEDIATRICA, Vol. 68, Iss. 5, 1979-09 ,pp. : 475-479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients

By vom Dahl Stephan   Poll Ludger   Di Rocco Maja   Ciana Giovanni   Denes Carmencita   Mariani Giuliano   Maas Mario  

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1045-1064

Informa Healthcare

Access to resources Recommend Favorite

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 584-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Goal-oriented therapy with miglustat in Gaucher disease

By Pastores Gregory M.   Giraldo Pilar   Chérin Patrick   Mehta Atul  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 23-37

Informa Healthcare

Access to resources Recommend Favorite

Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

By Matzner Ulrich   Matthes Frank   Weigelt Cecilia   Andersson Claes   Eistrup Carl   Fogh Jens   Gieselmann Volkmar  

Journal of Molecular Medicine, Vol. 86, Iss. 4, 2008-04 ,pp. : 433-442

Springer Publishing Company

Access to resources Recommend Favorite